99 related articles for article (PubMed ID: 11366080)
1. Are men and women really different?
Res Initiat Treat Action; 1998 Dec; 4(7):13. PubMed ID: 11366080
[TBL] [Abstract][Full Text] [Related]
2. Do women respond differently to HIV therapy than men?
Newsline People AIDS Coalit N Y; 1998 Dec; ():31. PubMed ID: 11367087
[TBL] [Abstract][Full Text] [Related]
3. Soft gel saquinavir has high exposure.
AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835
[TBL] [Abstract][Full Text] [Related]
4. New study of Fortovase (Saquinavir) in women.
WORLD; 1998 Nov; (No 91):4. PubMed ID: 11365973
[TBL] [Abstract][Full Text] [Related]
5. New formulation of saquinavir (Fortovase) is more effective.
Tam CW
Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
[TBL] [Abstract][Full Text] [Related]
6. Improved but not new.
Vazquez E
Posit Aware; 1997; 8(6):19. PubMed ID: 11364855
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P
Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062
[TBL] [Abstract][Full Text] [Related]
8. Women's nelfinavir (Viracept) trial.
Vazquez E
Posit Aware; 1997; 8(5):15. PubMed ID: 11364633
[TBL] [Abstract][Full Text] [Related]
9. Saquinavir, the pioneer antiretroviral protease inhibitor.
la Porte CJ
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048
[TBL] [Abstract][Full Text] [Related]
10. Lottery opens 2,000 slots for protease trial.
AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
[TBL] [Abstract][Full Text] [Related]
11. Goodbye, Invirase. Hello, Fortovase.
Vazquez E
Posit Aware; 1998; 9(1):45-6. PubMed ID: 11365001
[TBL] [Abstract][Full Text] [Related]
12. Saquinavir update.
Treat Rev; 1997 Aug; (No 25):6. PubMed ID: 11364616
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
14. Fortovase approved: new saquinavir formulation.
James JS
AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitors at a glance...
Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
[TBL] [Abstract][Full Text] [Related]
16. Study to address effects of antiretroviral therapy on women.
Hanna L
BETA; 1999 Apr; 12(2):16. PubMed ID: 11366677
[TBL] [Abstract][Full Text] [Related]
17. What they say about protease inhibitors.
Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection.
Wheat LJ; Farthing C; Cohen C; Pierone G; Lalezari J; Pilson RS; Siemon-Hryczyk P;
Antivir Ther; 2002 Sep; 7(3):199-209. PubMed ID: 12487388
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitor update.
Colvin R; Haas G
Common Factor; 1995 Apr; (no 10):15. PubMed ID: 11362340
[TBL] [Abstract][Full Text] [Related]
20. LaCARP seeks patients for study that will compare protease inhibitors.
Fac Notes (New Orleans La); 1998; 10(6):6. PubMed ID: 11366144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
